How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

AI is not overhyped. The potential requires equal attention to the less glamorous but more important role of data management.

Sougwen Chung is presenting new works as part of Art Basel Hong Kong’s inaugural Zero 10 sector, dedicated to art of the ...

The weird, rare, surprising patterns that make data rich slowly get smoothed out when an AI model trains on outputs from a ...

The market overvalues AGI as LLMs plateau, but BRK.A and UNH leverage AI for gains while others face bubble risks. Find out ...

While the energy is lively and the optimism palpable, dealers report the atmosphere is more measured than in previous years.

When Meta started building their Superintelligence team (MSL) in mid-2025, I certainly expected to see faster progress than ...

Mar. 26, 2026 Deepfake X-rays created by AI are now convincing enough to fool both doctors and AI models. In tests, radiologists had limited success identifying fake images, especially when they ...